Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.04%
#2 Pons Pons +38.47%
#3 Starpower Starpower +30.38%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.10%
#5 TENDIES TENDIES +24.03%
#6 Mubarak Mubarak +23.85%
#7 StonkBroker StonkBroker +21.99%
#8 SkyAI SkyAI +20.90%
#9 Decred Decred +19.75%
#10 PondCoin PondCoin +17.74%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
การตั้งค่า
ภาษา
ไทย
สกุลเงิน
USD
ธีม
Celularity Inc. Celularity Inc.

Celularity Inc.

CELU
อันดับในหุ้น #29250
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to... Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T therapy, currently in Phase I trials for B-cell malignancies; CYNK-001, an unmodified natural killer (NK) cell also from placental sources, advancing through Phase I trials for acute myeloid leukemia and Phase I/IIa trials for glioblastoma multiforme and COVID-19; and CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I for HER2+ gastric and gastroesophageal cancers. Furthermore, two mesenchymal-like adherent stromal cell candidates, APPL-001 and PDA-002 (both derived from placentas), are in pre-clinical development for Crohn's disease and facioscapulohumeral muscular dystrophy, respectively. In addition to its therapeutic development, Celularity is involved in commercial activities, offering surgical and wound care products like Biovance and Interfyl through sales and licensing agreements. The company also specializes in collecting stem cells from umbilical cords and placentas, providing storage services under its LifebankUSA brand. Founded in 2016, Celularity Inc. maintains its headquarters in Florham Park, New Jersey.
ราคาหุ้น
$0.7905
มูลค่าตลาด
$22.88M
การเปลี่ยนแปลง (1 วัน)
7.30%
การเปลี่ยนแปลง (1 ปี)
-78.10%
ประเทศ
US
ซื้อขาย Celularity Inc. (CELU)

หมวดหมู่

Healthcare
ประวัติราคาหุ้นของ Celularity Inc. (CELU)
ราคาปิดสูงสุด: $0.71 เมื่อ 2026-08-01

ราคาปิดต่ำสุด: $97.91 เมื่อ 2019-08-01
ประวัติราคาหุ้นของ Celularity Inc. ตั้งแต่ 2019 ถึง 2026
ผลการดำเนินงานราคาหุ้นรายปี
ปี ประสิทธิภาพ
2026 (TTM) -8.40%
2025 -30.04%
2024 12.55%
2023 -86.13%
2022 -72.74%
2021 -53.01%
2020 11.78%
2019 0.00%
ราคาหุ้นของบริษัทที่คล้ายกันหรือคู่แข่ง
บริษัท ราคาหุ้น การเปลี่ยนแปลง 1ปี% ประเทศ
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $546.15 39.77%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 55.21%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $155.84 458.35%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $117.42 -19.34%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $753.28 8.59%
CH